Clinical Diagnostics Insider

(formerly Diagnostic Testing and Emerging Technologies)

Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies

Diagnostics Pipeline: 2024 Trends in FDA Approvals

By Rachel Muenz | Jan 6, 2025 | 1 min read

In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests

A laboratory professional removes a test tube of blood from a rack on a lab bench, illustrating the concept of lab tests involving blood.

A Closer Lab-Patient Connection

By Oscelle Boye, MBiomed | Dec 17, 2024 | 1 min read

Patient access to data from the clinical lab is increasing. What does this mean for those generating it?

An illustration of a male patient interacting with a female laboratory professional on a laptop.

New and Improved: The Latest Research in Disease Screening

By Michael Schubert, PhD | Dec 17, 2024 | 1 min read

New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes

Closeup image of blue and yellow liquid being pipetted intro microwells, illustrating disease screening.

Blood Test Could Improve CAD Diagnosis

By Glenn S. Demby | May 2, 2017 | 1 min read

From - Diagnostic Testing & Emerging Technologies
A simple blood test can accurately, noninvasively, and quickly diagnose heart disease, according to a study published in the…

. . . read more

Genomic Markers May ID Risk of Chemo Side Effects

By Glenn S. Demby | Apr 24, 2017 | 1 min read

From - Diagnostic Testing & Emerging Technologies
While much attention is focused on using genomic markers to target the effectiveness of treatments, simultaneous research is exploring use of genomic markers to…

. . . read more

Screening Test Use Up After ACA

By Glenn S. Demby | Apr 18, 2017 | 1 min read

From - Diagnostic Testing & Emerging Technologies
There was an uptick in preventive screening after enactment of the Affordable Care Act (ACA), yet cancer-screening rates in the United States remain below…

. . . read more